Sign in
4

Changes in Ownership

Alto Neuroscience, Inc. Filed Acc 0002009130-26-000004

PRESIDENT AND CFO sold 134,886 shares at an average $26.45 ($3,567,247)

  • PRESIDENT AND CFO acquired 134,886 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Smith Nicholas Conrad · PRESIDENT AND CFO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-29 Exercise or conversion : show line 1 in the form +56,455 $2.35 $132,669 80,515 D
2026-09-29 Exercise or conversion : show line 2 in the form +54,375 $2.35 $127,781 134,890 D
2026-09-29 Sale : show line 3 in the form −110,830 $26.58 $2,946,150 24,060 D
2026-09-30 Exercise or conversion : show line 4 in the form +24,056 $2.35 $56,532 48,116 D
2026-09-30 Sale : show line 5 in the form −23,170 $25.78 $597,290 24,946 D
2026-09-30 Sale : show line 6 in the form −886 $26.87 $23,807 24,060 D
Open-market sales · 134,886 sh · avg $26.45 · $3,567,247

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-09-29 Exercise or conversion : show line 7 in the form Employee Stock Option (Right to Buy) −56,455 145,874 D
2026-09-29 Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Buy) −54,375 35,625 D
2026-09-30 Exercise or conversion : show line 9 in the form Employee Stock Option (Right to Buy) −24,056 121,818 D
Loading xslF345X06/wk-form4_1790904813.xml…